These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 33372800)
21. Tritium-labeled agonists as tools for studying adenosine A Hinz S; Alnouri WM; Pleiss U; Müller CE Purinergic Signal; 2018 Sep; 14(3):223-233. PubMed ID: 29752618 [TBL] [Abstract][Full Text] [Related]
22. Identification of V6.51L as a selectivity hotspot in stereoselective A Wang X; Jespers W; Prieto-Díaz R; Majellaro M; IJzerman AP; van Westen GJP; Sotelo E; Heitman LH; Gutiérrez-de-Terán H Sci Rep; 2021 Jul; 11(1):14171. PubMed ID: 34238993 [TBL] [Abstract][Full Text] [Related]
23. The hybrid molecule, VCP746, is a potent adenosine A2B receptor agonist that stimulates anti-fibrotic signalling. Vecchio EA; Chuo CH; Baltos JA; Ford L; Scammells PJ; Wang BH; Christopoulos A; White PJ; May LT Biochem Pharmacol; 2016 Oct; 117():46-56. PubMed ID: 27520486 [TBL] [Abstract][Full Text] [Related]
25. Replacement of amide with bioisosteres led to a new series of potent adenosine A2A receptor antagonists. Yang Z; Li X; Ma H; Zheng J; Zhen X; Zhang X Bioorg Med Chem Lett; 2014 Jan; 24(1):152-5. PubMed ID: 24332624 [TBL] [Abstract][Full Text] [Related]
26. The A Mølck C; Ryall J; Failla LM; Coates JL; Pascussi JM; Heath JK; Stewart G; Hollande F Cancer Lett; 2016 Dec; 383(1):135-143. PubMed ID: 27693637 [TBL] [Abstract][Full Text] [Related]
27. Design, synthesis, and biological evaluation of new 8-heterocyclic xanthine derivatives as highly potent and selective human A2B adenosine receptor antagonists. Baraldi PG; Tabrizi MA; Preti D; Bovero A; Romagnoli R; Fruttarolo F; Zaid NA; Moorman AR; Varani K; Gessi S; Merighi S; Borea PA J Med Chem; 2004 Mar; 47(6):1434-47. PubMed ID: 14998332 [TBL] [Abstract][Full Text] [Related]
28. Discovery of novel quinolinone adenosine A2B antagonists. McGuinness BF; Ho KK; Stauffer TM; Rokosz LL; Mannava N; Kultgen SG; Saionz K; Klon A; Chen W; Desai H; Rogers WL; Webb M; Yin J; Jiang Y; Li T; Yan H; Jing K; Zhang S; Majumdar KK; Srivastava V; Saha S Bioorg Med Chem Lett; 2010 Dec; 20(24):7414-20. PubMed ID: 21055932 [TBL] [Abstract][Full Text] [Related]
29. Discovery and characterization of 4'-(2-furyl)-N-pyridin-3-yl-4,5'-bipyrimidin-2'-amine (LAS38096), a potent, selective, and efficacious A2B adenosine receptor antagonist. Vidal B; Nueda A; Esteve C; Domenech T; Benito S; Reinoso RF; Pont M; Calbet M; López R; Cadavid MI; Loza MI; Cárdenas A; Godessart N; Beleta J; Warrellow G; Ryder H J Med Chem; 2007 May; 50(11):2732-6. PubMed ID: 17469811 [TBL] [Abstract][Full Text] [Related]
30. Structure-activity relationships of 2,N(6),5'-substituted adenosine derivatives with potent activity at the A2B adenosine receptor. Adachi H; Palaniappan KK; Ivanov AA; Bergman N; Gao ZG; Jacobson KA J Med Chem; 2007 Apr; 50(8):1810-27. PubMed ID: 17378544 [TBL] [Abstract][Full Text] [Related]
31. New A Lambertucci C; Spinaci A; Buccioni M; Dal Ben D; Ngouadjeu Ngnintedem MA; Kachler S; Marucci G; Klotz KN; Volpini R Bioorg Chem; 2019 Nov; 92():103183. PubMed ID: 31446240 [TBL] [Abstract][Full Text] [Related]
32. BAY60-6583 acts as a partial agonist at adenosine A2B receptors. Hinz S; Lacher SK; Seibt BF; Müller CE J Pharmacol Exp Ther; 2014 Jun; 349(3):427-36. PubMed ID: 24633424 [TBL] [Abstract][Full Text] [Related]
33. The second extracellular loop of GPCRs determines subtype-selectivity and controls efficacy as evidenced by loop exchange study at A2 adenosine receptors. Seibt BF; Schiedel AC; Thimm D; Hinz S; Sherbiny FF; Müller CE Biochem Pharmacol; 2013 May; 85(9):1317-29. PubMed ID: 23500543 [TBL] [Abstract][Full Text] [Related]
35. The four cysteine residues in the second extracellular loop of the human adenosine A2B receptor: role in ligand binding and receptor function. Schiedel AC; Hinz S; Thimm D; Sherbiny F; Borrmann T; Maass A; Müller CE Biochem Pharmacol; 2011 Aug; 82(4):389-99. PubMed ID: 21620804 [TBL] [Abstract][Full Text] [Related]
36. The Many Faces of the A2b Adenosine Receptor in Cardiovascular and Metabolic Diseases. Eisenstein A; Patterson S; Ravid K J Cell Physiol; 2015 Dec; 230(12):2891-7. PubMed ID: 25975415 [TBL] [Abstract][Full Text] [Related]
37. 2,4,6-trisubstituted pyrimidines as a new class of selective adenosine A1 receptor antagonists. Chang LC; Spanjersberg RF; von Frijtag Drabbe Künzel JK; Mulder-Krieger T; van den Hout G; Beukers MW; Brussee J; Ijzerman AP J Med Chem; 2004 Dec; 47(26):6529-40. PubMed ID: 15588088 [TBL] [Abstract][Full Text] [Related]
38. Dual targeting of adenosine A(2A) receptors and monoamine oxidase B by 4H-3,1-benzothiazin-4-ones. Stössel A; Schlenk M; Hinz S; Küppers P; Heer J; Gütschow M; Müller CE J Med Chem; 2013 Jun; 56(11):4580-96. PubMed ID: 23631427 [TBL] [Abstract][Full Text] [Related]
39. Pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine derivatives as highly potent and selective human A(3) adenosine receptor antagonists: influence of the chain at the N(8) pyrazole nitrogen. Baraldi PG; Cacciari B; Romagnoli R; Spalluto G; Moro S; Klotz KN; Leung E; Varani K; Gessi S; Merighi S; Borea PA J Med Chem; 2000 Dec; 43(25):4768-80. PubMed ID: 11123985 [TBL] [Abstract][Full Text] [Related]
40. 5-amino-2-phenyl[1,2,3]triazolo[1,2-a][1,2,4]benzotriazin-1-one: a versatile scaffold to obtain potent and selective A3 adenosine receptor antagonists. Da Settimo F; Primofiore G; Taliani S; Marini AM; La Motta C; Simorini F; Salerno S; Sergianni V; Tuccinardi T; Martinelli A; Cosimelli B; Greco G; Novellino E; Ciampi O; Trincavelli ML; Martini C J Med Chem; 2007 Nov; 50(23):5676-84. PubMed ID: 17927167 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]